Rotaviruses (RVs) are responsible for more than 600,000 child deaths each year. The worldwide introduction of two life oral vaccines RotaTeq and Rotarix is believed to reduce this number significantly. Before the licensing of both vaccines, two new genotypes, G9 and G12, emerged in the human population and were able to spread across the entire globe in a very short time span. To quantify the VP7 mutation rates of these G9 and G12 genotypes and to estimate their most recent common ancestors, we used a Bayesian Markov chain Monte Carlo framework. Based on 356 sequences for G9 and 140 sequences for G12, we estimated mutation rates (nt substitutions/site/year) of 1.87 Â 10 À3 (1.45-2.27 Â 10
Introduction
Rotaviruses (RVs) are a major cause of acute gastroenteritis in infants and young children worldwide and in the young of a large variety of animals ). RV disease is associated with more than 600,000 deaths of infants and young children per year, mainly in developing countries (Parashar et al. 2006) . Since 2006, two live attenuated RV vaccines, Rotarix and RotaTeq, have been licensed in many countries around the world after they were shown to be efficacious and safe in very large phase III clinical trials (Ruiz-Palacios et al. 2006; Vesikari et al. 2006; Block et al. 2007; Linhares et al. 2008; Matthijnssens, Joelsson, et al. 2010 ). More and more evidence is becoming available about the effect of vaccine introduction on the burden of disease caused by RV infections, and spectacular reductions have been noted in the United States, Austria, and Belgium (Matthijnssens, Bilcke, et al. 2009; Paulke-Korinek et al. 2009 ).
RVs possess a genome composed of 11 segments of double-stranded RNA, encoding six structural viral proteins (VPs) and five or six nonstructural proteins (Estes and Kapikian 2007) . The outer capsid is composed of VP7 protruded by spikes of VP4, which are used to classify RVs into G-and P-genotypes, respectively. Currently, 23 G-genotypes and 31 P-genotypes have been reported for human and animal RVs Schumann et al. 2009; Ursu et al. 2009 ). RVs use several mechanisms to generate genetic diversity. Reassortment between RVs from the same or different host species, occurring after coinfections of a host, has been shown to be an important mechanism to generate diversity on many occasions Matthijnssens, Bilcke, et al. 2009; McDonald et al. 2009 ). Interspecies transmissions of RVs between multiple hosts are also believed to have a significant influence on the evolution of RVs Tsugawa and Hoshino 2008; Matthijnssens, Potgieter, et al. 2009; Matthijnssens, Taraporewala, et al. 2009; Matthijnssens, Rahman, et al. 2010 ). Other less important mechanisms such as inter-or intragenic recombination are believed to occur less frequently (Desselberger 1996; Cao, Barro, et al. 2008) . Point mutations are being accumulated constantly in each replication cycle of RVs due to the error-prone nature of the viral-encoded RNA-dependent RNA polymerase (RdRp), mainly resulting in genetic drift (Ciarlet and Estes 2002) . The rate at which these mutations accumulate for group A RVs is poorly studied. RV in vitro studies have estimated that one mutation per genome per replication would be introduced by the viral RdRp (Blackhall et al. 1996) , but the rate at which these mutations accumulate in the RV population is not well characterized.
Before 1995, G1, G2, G3, and G4 were worldwide the most prevalent human RV VP7 genotypes . Since 1995, the G9 genotype has emerged worldwide and is now considered to be the fifth major human RV genotype (Rahman et al. 2005; Matthijnssens, Rahman, et al. 2008) . Phylogenetic analyses have revealed that a single sublineage of G9 RV strains was responsible for this worldwide spread. In addition, G12 genotype strains have been found to circulate in most parts of the world since the start of the new millennium, and this emerging G12 might become the sixth major human RV genotype (Rahman et al. 2007; Matthijnssens, Bilcke, et al. 2009 ). Comparable with G9, a single G12 lineage was found responsible for the worldwide spread. For both G9 and G12, the origin is unclear, although pigs are suspected as a potential host reservoir for these genotypes, as this is the only species, besides humans, from which G9 and G12 RVs have been isolated to date (Matthijnssens, Rahman, et al. 2008 ).
Materials and Methods
For 9 porcine and 347 human G9 RV strains, the entire VP7 ORF sequences and the year of isolation could be retrieved from GenBank or by contacting the authors of the sequences when no year of isolation was provided in GenBank. For a single porcine and 139 human G12 RV strains, the entire VP7 ORF sequences and the year of isolation could be retrieved.
Bayesian phylogenetic reconstructions were performed using Markov chain Monte Carlo (MCMC) analysis implemented in BEAST (Drummond and Rambaut 2007) . BEAST incorporates molecular clock models to estimate rooted, time-measured phylogenetic trees with a coalescent prior. By averaging over all plausible trees, the Bayesian MCMC approach takes into account phylogenetic error.
We analyzed both genotypes using an HKY nucleotide substitution model with gamma-distributed rate variation, a lognormal relaxed clock model (Drummond et al. 2006 ) and a flexible Bayesian skyline tree prior (Drummond et al. 2005) . For each genotype, four independent MCMC analyses were run for 100 million generations and diagnosed using Tracer (http://tree.bio.ed.ac.uk/software/ tracer). Maximum clade credibility trees were annotated using TreeAnnotator and visualized in FigTree (http://tree. bio.ed.ac.uk/software/figtree/). For evolutionary rates, we report weighted average rates across branches in the tree distribution (Drummond et al. 2006) .
Results
The evolutionary rate for G9 was estimated to be 1.87 Â 10 À3 (1.45-2.27 Â 10
À3
) nt substitutions/site/year, and a coefficient of variation of about 1.4 indicates significant rate variation among branches (within about 140% of the mean rate). The credible intervals for the latter (1.0-1.7) clearly exclude zero, which justifies the use of a relaxed molecular clock (table 1) . For G9, three human lineages were initially established. Lineages I and II contain the first described G9 reference strains isolated in the 1980s ( fig. 1A ). Lineage III is subdivided into a minor and a major sublineage. The minor sublineage contains unusual human and porcine G9P[19] RV strains, whereas the major subcluster contains the large majority of the currently circulating G9P[4], G9P [6] , and G9P[8] strains (Matthijnssens, Rahman, et al. 2008) . A small number of human and porcine G9 strains have now been described, which do not belong to any of these three initially established lineages (Oka et al. 2000; Doan et al. 2003; Laird et al. 2003; Zhou et al. 2003; Teodoroff et al. 2005; Cao, Santoz, et al. 2008) . From these strains, an interesting subgroup contains human and porcine G9 RV strains isolated in Japan and China ( fig. 1A) .
Bayesian inference from sequences sampled over time allows us to simultaneously estimate substitution rates and the time of the most recent common ancestor (TMRCA) for related groups of RVs. The TMRCA for the major subcluster of G9 Lineage III (containing more than 90% of all currently known G9 strains) was calculated to be 1989 with a 95% credible interval of 1986-1992 ( fig. 1A and table 1). A review of the literature suggests that these Lineage III G9 RVs were detected in surveillance networks around the world by the start of the new millennium (Matthijnssens, Rahman, et al. 2008) . This suggests that a single G9 VP7 gene segment was present in strains circulating in the late-1980s or early 1990s, which were able to spread and cause disease across the entire globe in just over a decade. A second interesting estimate is the divergence time of 1985 (1976-1993) for the porcine and human G9 subclusters isolated in Japan and China around the change of the millennium ( fig. 1A and table 1 ). This suggests that in the mid-1980s, an interspecies transmission might have Global TMRCA 1927 (1879 -1962 ) 1956 (1927 -1982 ) TMRCA Lineage III (G9 and G12) 1981 (1974 -1986 ) 1995 (1992 -1998 MBE occurred from a RV from a porcine to a human host or vice versa, not only resulting in a successful infection but also a transmission among members of the new host species. The fact that the diversity inside the porcine subcluster appears to be greater than the diversity inside the human subcluster is suggestive for a transmission from a porcine to a human host (Teodoroff et al. 2005 ). The evolutionary rate for G12 was calculated to be 1.66 Â 10 À3 (1.10-2.20 Â 10
) nt substitutions/site/year (table 1) . Again, the coefficient of variation indicated considerable rate variation among branches, which invalidates the use of a strict molecular clock (table 1). The G12 genotype is subdivided into four lineages (Matthijnssens, Rahman, et al. 2008 ). Lineage I only contains the first 1990 1980 1970 1960 1950 1940 1930 1880 1927 [1879-1962] 1989 [1986] [1987] [1988] [1989] [1990] [1991] [1992] 1998 and 2008 1956 [1927-1982] 1970 1995 [1992] [1993] [1994] [1995] [1996] [1997] [1998] 1996 [1994] [1995] [1996] [1997] [1998] [1999] (Kobayashi et al. 1989) . Lineage II contains G12P [9] strains isolated in South America and Asia ( fig. 1B) (Matthijnssens, Bilcke, et al. 2009 ). Lineage IV contains RU172 the only porcine G12 strain known to date found in combination with P[7] (Ghosh et al. 2006) . Comparable with G9, the majority of the currently known G12 strains (more than 90% and in combination with P[8] or P[6]) cluster in a single lineage (Lineage III) (fig. 1B) . The TMRCA of these Lineage III strains was dated back to 1995 (1992-1998) (table 1) , and because G12 strains belonging to Lineage III are currently being detected worldwide (Matthijnssens, Bilcke, et al. 2009 ), this again suggests that strains carrying a particular G12 VP7 gene segment were able to spread across the globe and cause disease in little more than a decade. The G12P[9] strains from G12 Lineage II were estimated to have a TMRCA around 1996 TMRCA around (1994 TMRCA around -1999 (table 1) , and this G12 variant was able to spread to South America (Brazil and Argentina) and Asia (Japan, South Korea, and Thailand), although the frequency of detection is much lower than the Lineage III G12 strains (Matthijnssens, Bilcke, et al. 2009 ). The TMRCA between the first detected G12 strain L26 (Lineage I) and the only currently known porcine G12 strain (Lineage IV) was dated back to 1970 (1952-1985) , and the TMRCA between all currently known G12 strains was estimated around1956 (fig.1B and table 1) . At present, the origin of G12 strains remains obscure, as they were only detected on a single occasion in humans before 1998, and only a single porcine G12 strains is currently know (Matthijnssens, Bilcke, et al. 2009 ).
Mutation Rate Analyses of G9 and G12 Rotaviruses
· doi:10.1093/molbev/msq137 MBE detected G12P[4] strain L26, detected in the Philippines in 1987
Discussion
Evolutionary rates have been calculated for several RNA viruses and range typically from more than 1 Â 10 À3 to as low as 1 Â 10 À6 substitutions/site/year (Jenkins et al. 2002) . Some examples are 6.7 Â 10 À3 substitutions/site/ year for the V3 gene of HIV-1 (Leitner and Albert 1999), 5.7 Â 10 À3 for the HA1 gene of H3N2 influenza viruses (Fitch et al. 1997 ), 1.9 Â 10 À3 for the G protein of respiratory syncytial virus B (Zlateva et al. 2005) , 5.8 Â 10
À4 for the VP4 gene of human RVs (Jenkins et al. 2002) , 5.0 Â 10
À4
for the H gene of measles virus (Rima et al. 1997) , and 9.0 Â 10 À6 for GB virus C (Suzuki et al. 1999 ). The evolutionary rates calculated for the VP7 gene of G9 and G12 RVs (1.87 Â 10 À3 and 1.66 Â 10 À3 substitutions/site/year, respectively) fall in the high end of this spectrum. This is not very surprising because VP7 is one of the most variable RV proteins and an outer capsid protein, subjected to a constant immunological pressure, which could increase the evolutionary rate.
For both G9 and G12 RVs, a number of genetically different variants have been isolated from humans, but only closely related strains belonging to a single lineage (Lineage III for G12 and the major subcluster in Lineage III for G9) have been able to spread and cause disease across the globe. Our evolutionary inference analyses together with the relatively well-known timing of the epidemiological spread of the G9 and G12 human RVs all over the world (Matthijnssens, Rahman, et al. 2008; Matthijnssens, Bilcke, et al. 2009 ) allowed us to calculate that this spread worldwide has occurred in little more than a decade. This appears to be an incredible short time period and a fast spread, and this should be realized by epidemiologists and health care professionals. Although the G9 and especially G12 RV genotypes have received only recently the full attention of researchers, our estimates suggest that they must have been around at least since the 1920s and 1950s, respectively, in the human or an animal host. Another surprising observation was that a number of the Japanese and Chinese porcine and human G9 strains were placed in a monophyletic cluster by our Bayesian phylogenetic reconstructions ( fig. 1A ), whereas these strain were found to cluster dispersed between other strains in previous analyses using other phylogenetic algorithms such as the neighbor joining method (Phan et al. 2007; Matthijnssens, Rahman, et al. 2008) . Our estimates suggest an interspecies transmission between a human and a pig (or vice versa) in the mid-1980s (fig. 1A) . The current data suggest the occurrence of interspecies transmissions of RVs between human and porcine hosts, but they do not allow us to pinpoint the original host of origin for either the G9 or the G12 RV strains, and an increased surveillance in animals and especially in pigs will be necessary to answer this question.
The recent introduction of two RV vaccines, Rotarix and RotaTeq, into the human population may impose an additional selective pressure on circulating RV strains, possibly influencing their evolutionary rate. The capability of new RV variants (e.g., vaccine escape mutants or new reassortants) to diffuse worldwide in a period as short as a decade, and maybe even faster with the ever increasing movement and traveling of people all over the world, could be a challenge for RV vaccine and emphasizes the need for a continued and increased close monitoring of circulating RV strains around the world.
